Profil
Franzpeter Bracht is the founder of Lindis Blood Care GmbH, which was founded in 2018, where he holds the title of MD-Finance, Strategy & Business Development.
He is currently the Managing Director at Bracht Beteiligungsgesellschaft mbH.
Dr. Bracht's former positions include Chief Operating Officer at Glycotope GmbH and Celonic AG.
Postes actifs de Franzpeter Bracht
| Sociétés | Poste | Début |
|---|---|---|
Lindis Blood Care GmbH
 Lindis Blood Care GmbH Medical SpecialtiesHealth Technology Lindis Blood Care GmbH engages in the development and manufacture of autologous blood transfusion devices. It specializes in blood transfusion and intraoperative blood salvage. The company was founded by Horst Lindhofer and Franzpeter Bracht in January 2018 and is headquartered in Hennigsdorf, Germany. | Fondateur | 01/01/2018 |
Bracht Beteiligungsgesellschaft mbH
 Bracht Beteiligungsgesellschaft mbH Financial ConglomeratesFinance Bracht Beteiligungsgesellschaft mbH engages in the investment in companies. It also provides consulting services to firms. The company was founded on August 22, 2003 and is headquartered in Berlin, Germany. | Directeur Général | - |
Anciens postes connus de Franzpeter Bracht
| Sociétés | Poste | Fin |
|---|---|---|
Celonic AG
 Celonic AG BiotechnologyHealth Technology Celonic AG engages in the development and contract manufacturing of biologics. It offers services such as cell line development, upstream and downstream processing development, good manufacturing process manufacturing, and fill and finish services for liquid formulated drug products. The company is headquartered in Basel, Switzerland. | Directeur des opérations | - |
Glycotope GmbH
 Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Glycotope GmbH
Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Health Technology |
Celonic AG
Celonic AG BiotechnologyHealth Technology Celonic AG engages in the development and contract manufacturing of biologics. It offers services such as cell line development, upstream and downstream processing development, good manufacturing process manufacturing, and fill and finish services for liquid formulated drug products. The company is headquartered in Basel, Switzerland. | Health Technology |
Lindis Blood Care GmbH
Lindis Blood Care GmbH Medical SpecialtiesHealth Technology Lindis Blood Care GmbH engages in the development and manufacture of autologous blood transfusion devices. It specializes in blood transfusion and intraoperative blood salvage. The company was founded by Horst Lindhofer and Franzpeter Bracht in January 2018 and is headquartered in Hennigsdorf, Germany. | Health Technology |
Bracht Beteiligungsgesellschaft mbH
Bracht Beteiligungsgesellschaft mbH Financial ConglomeratesFinance Bracht Beteiligungsgesellschaft mbH engages in the investment in companies. It also provides consulting services to firms. The company was founded on August 22, 2003 and is headquartered in Berlin, Germany. | Finance |
